• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2受体亚型在不同系统中的细胞分布及功能

Cellular distribution and functions of P2 receptor subtypes in different systems.

作者信息

Burnstock Geoffrey, Knight Gillian E

机构信息

Autonomic Neuroscience Institute, Royal Free and University College Medical School, London NW3 2PF, United Kingdom.

出版信息

Int Rev Cytol. 2004;240:31-304. doi: 10.1016/S0074-7696(04)40002-3.

DOI:10.1016/S0074-7696(04)40002-3
PMID:15548415
Abstract

This review is aimed at providing readers with a comprehensive reference article about the distribution and function of P2 receptors in all the organs, tissues, and cells in the body. Each section provides an account of the early history of purinergic signaling in the organ?cell up to 1994, then summarizes subsequent evidence for the presence of P2X and P2Y receptor subtype mRNA and proteins as well as functional data, all fully referenced. A section is included describing the plasticity of expression of P2 receptors during development and aging as well as in various pathophysiological conditions. Finally, there is some discussion of possible future developments in the purinergic signaling field.

摘要

本综述旨在为读者提供一篇关于P2受体在人体所有器官、组织和细胞中的分布及功能的全面参考文章。每一部分都介绍了截至1994年该器官或细胞中嘌呤能信号传导的早期历史,然后总结了随后关于P2X和P2Y受体亚型mRNA和蛋白质存在的证据以及功能数据,所有这些都有充分的参考文献。其中包括一部分内容,描述了P2受体在发育、衰老以及各种病理生理条件下表达的可塑性。最后,对嘌呤能信号传导领域未来可能的发展进行了一些讨论。

相似文献

1
Cellular distribution and functions of P2 receptor subtypes in different systems.P2受体亚型在不同系统中的细胞分布及功能
Int Rev Cytol. 2004;240:31-304. doi: 10.1016/S0074-7696(04)40002-3.
2
P2 receptor signaling in neurons and glial cells of the central nervous system.中枢神经系统神经元和神经胶质细胞中的P2受体信号传导
Adv Pharmacol. 2011;61:441-93. doi: 10.1016/B978-0-12-385526-8.00014-X.
3
P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.P2X和P2Y受体作为中枢神经系统疾病治疗干预的潜在靶点。
Drug News Perspect. 2005 Mar;18(2):85-101. doi: 10.1358/dnp.2005.18.2.886479.
4
Involvement of P2 receptors in the growth and survival of neurons in the CNS.P2受体在中枢神经系统神经元生长与存活中的作用。
Pharmacol Ther. 2006 Mar;109(3):297-324. doi: 10.1016/j.pharmthera.2005.06.002. Epub 2005 Aug 15.
5
Neuronal and glial cell lines as model systems for studying P2Y receptor pharmacology.神经元和神经胶质细胞系作为研究P2Y受体药理学的模型系统。
Neurochem Int. 2005 Nov;47(6):401-12. doi: 10.1016/j.neuint.2005.05.012.
6
Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia.细胞外核苷酸在神经胶质细胞中的病理生理作用:静息和活化小胶质细胞中嘌呤能受体的差异表达。
Brain Res Brain Res Rev. 2005 Apr;48(2):144-56. doi: 10.1016/j.brainresrev.2004.12.004. Epub 2005 Jan 22.
7
Do ATP and NO interact in the CNS?三磷酸腺苷(ATP)和一氧化氮(NO)在中枢神经系统中会相互作用吗?
Prog Neurobiol. 2008 Jan;84(1):40-56. doi: 10.1016/j.pneurobio.2007.10.004. Epub 2007 Oct 18.
8
Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat.大鼠培养皮质星形胶质细胞中P2X和P2Y受体亚型导致细胞内钙离子增加。
Neuroscience. 2009 Jun 2;160(4):767-83. doi: 10.1016/j.neuroscience.2009.02.026. Epub 2009 Mar 13.
9
Salivary gland nucleotide receptors: evidence for functional expression of both P2X and P2Y subtypes.唾液腺核苷酸受体:P2X和P2Y亚型功能性表达的证据。
Eur J Morphol. 1998 Aug;36 Suppl:170-5.
10
Purinergic signalling and disorders of the central nervous system.嘌呤能信号传导与中枢神经系统疾病
Nat Rev Drug Discov. 2008 Jul;7(7):575-90. doi: 10.1038/nrd2605.

引用本文的文献

1
Design, Synthesis and Anti-Inflammation Evaluation of -Acyl Tryptophan Derivatives as Promising P2YR Antagonists Against Lipopolysaccharide-Induced Acute Lung Injury.作为有望对抗脂多糖诱导的急性肺损伤的P2YR拮抗剂的α-酰基色氨酸衍生物的设计、合成及抗炎评价
Drug Des Devel Ther. 2025 Aug 20;19:7215-7245. doi: 10.2147/DDDT.S497291. eCollection 2025.
2
New insights into pathogenisis and therapies of P2X7R in Parkinson's disease.帕金森病中P2X7受体发病机制及治疗的新见解。
NPJ Parkinsons Dis. 2025 May 5;11(1):108. doi: 10.1038/s41531-025-00980-7.
3
Patients with periodontal disease demonstrates changes in purinergic and inflammatory markers in PBMCs, serum and saliva.
牙周病患者的外周血单核细胞、血清和唾液中的嘌呤能和炎症标志物出现变化。
Purinergic Signal. 2025 Mar 16. doi: 10.1007/s11302-025-10082-x.
4
Extracellular ATP: an emerging multifaceted regulator of plant fitness.细胞外ATP:一种新兴的植物适应性多面调节因子。
Plant Biotechnol J. 2025 May;23(5):1771-1782. doi: 10.1111/pbi.70006. Epub 2025 Feb 12.
5
P2Y6R Inhibition Induces Microglial M2 Polarization by Promoting PINK1/Parkin-Dependent Mitophagy After Spinal Cord Injury.脊髓损伤后,P2Y6R抑制通过促进PINK1/帕金依赖性线粒体自噬诱导小胶质细胞M2极化。
Mol Neurobiol. 2025 Jun;62(6):7054-7074. doi: 10.1007/s12035-024-04631-5. Epub 2024 Nov 28.
6
Impact of the adenosine receptor A2BR expressed on myeloid cells on immune regulation during pregnancy.髓系细胞上表达的腺苷受体A2BR对孕期免疫调节的影响。
Eur J Immunol. 2024 Dec;54(12):e2451149. doi: 10.1002/eji.202451149. Epub 2024 Oct 25.
7
Rosmarinic acid modulates purinergic signaling and induces apoptosis in melanoma cells.迷迭香酸调节嘌呤能信号传导并诱导黑色素瘤细胞凋亡。
Purinergic Signal. 2025 Apr;21(2):353-363. doi: 10.1007/s11302-024-10040-z. Epub 2024 Jul 20.
8
How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.选择性拮抗剂和基因改造如何有助于表征血管P2Y受体的表达和功能。
Purinergic Signal. 2025 Feb;21(1):11-22. doi: 10.1007/s11302-024-10016-z. Epub 2024 May 13.
9
The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation.嘌呤能受体 P2X7 作为病毒载体介导的抗原交叉呈递的调节剂。
Front Immunol. 2024 Apr 22;15:1360140. doi: 10.3389/fimmu.2024.1360140. eCollection 2024.
10
Unveiling orphan receptor-like kinases in plants: novel client discovery using high-confidence library predictions in the Kinase-Client (KiC) assay.揭示植物中类孤儿受体激酶:在激酶-底物(KiC)分析中使用高可信度文库预测发现新底物
Front Plant Sci. 2024 Apr 3;15:1372361. doi: 10.3389/fpls.2024.1372361. eCollection 2024.